Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.

The utility of current chemotherapeutic regimens in the treatment of AIDS-related Kaposi's sarcoma (AIDS-KS) is often compromised by both limited efficacy and substantial toxicity. Pegylated (Stealth) liposomal doxorubicin hydrochloride (SL-DOX) has been demonstrated specifically to deliver hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Goebel, F. D., Goldstein, D., Goos, M., Jablonowski, H., Stewart, J. S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075823/
https://www.ncbi.nlm.nih.gov/pubmed/8611437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075823/
https://www.ncbi.nlm.nih.gov/pubmed/8611437

Ejemplares similares